Pain in cancer patients unrelated to the cancer or treatment

Cancer Investigation

Volumn 23, Issue 1, 2005, Pages 84-93

  Marcus, Norman J ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Norman Marcus Pain Institute   (United States)

Author keywords

Cancer; Muscle Pain; Pain Treatment; Pain Unrelated to Cancer

Indexed keywords

AMPHOTERICIN B; BACLOFEN; BOTULINUM TOXIN; BRADYKININ; CIMETIDINE; CISPLATIN; CLOFIBRATE; DIURETIC AGENT; GABAPENTIN; HISTAMINE; LIDOCAINE; LITHIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROKININ 1 RECEPTOR; NITRIC OXIDE; PROSTAGLANDIN E2; QUININE; SPASMOLYTIC AGENT; SUBSTANCE P; TIZANIDINE; VINCRISTINE;

ADVANCED CANCER; ANTERIOR HORN CELL DISEASE; CARDIOTOXICITY; CHRONIC PAIN; CONFERENCE PAPER; DRUG HALF LIFE; DRUG INDUCED DISEASE; ELECTROSTIMULATION THERAPY; EXERCISE; EYE TOXICITY; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LOW BACK PAIN; LOW DRUG DOSE; MENTAL STRESS; METABOLIC DISORDER; MUSCLE CRAMP; MUSCLE DISEASE; MUSCLE SPASM; MUSCLE WEAKNESS; MYALGIA; MYOFASCIAL PAIN; NAUSEA; NEUROPATHIC PAIN; PALPATION; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHOTHERAPY; RADICULOPATHY; SYSTEMATIC REVIEW; TINNITUS;

EID: 14844286431     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1081/CNV-46516     Document Type: Conference Paper

References (58)

1. Behan, R.J. Pain: Its Origin, Conduction, Perception, and Diagnostic Significance: D. Appleton & Company: New York, 1921.
2. Bonica, J.J. The management of pain. In The Management of Pain, 2nd Ed.; Bonica, J.J., Ed.; Lea and Febiger: Malvern, PA, 1990; pp. 18, 180.
3. Cullinane, C.A.; Chu, D.Z.; Mamelak, A.N. Current surgical options in the control of cancer pain. Cancer Practice 2002, 10 (1), 21-26.
4. Abrams, S.E. The role of nonneurolytic nerve blocks in the management of cancer pain. In Cancer Pain; Kluwer Academic: Boston, 1989.
5. Marcus, N.J. Failure to diagnose pain of muscular origin leads to unnecessary surgery. Pain Med. 2002, 3 (2), 161-166.
6. Grond, S.; Zech, D.; Diefenbeach, C.; Radbruch, L.; Lehman, K.A. Assessment of cancer pain: a prospective evaluation in 2,266 cancer patients referred to a pain service. Pain 1996, 64 (1), 107-114.
7. Vuorinen, E. Pain as an early symptom in cancer. Clin. J. Pain 1993, 9 (4), 272-278.
8. Grond, S.; Zech, D.; Lynch, J.; Diefenbach, C.; Schug, S.A.; Lehman, K.A. Validation of World Health Organization guidelines for pain relief in head and neck cancer: a prospective study. Ann. Oncol. 1993, 102 (2), 342-348.
9. Clouston, P.D.; De Angelis, L.M.; Posner, J.B. The spectrum of neurological disease in patients with systemic cancer. Ann. Neurol. 1992, 31 (3), 268-273.
10. Shapiro, B.S.; Cohen, D.E.; Covelman, K.W.; Howe, C.J.; Scott, S.M. Experience of an interdisciplinary pediatric pain service. Pediatrics 1991, 88 (6), 1226-1235.
11. Twycross, R. Symptom Management in Advanced Cancer. Radcliffe Medical Press: Oxford, 1995; 14.
12. Banning, A.; Sjogren, P.; Henniksen, H. Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic. Pain 1991, 45 (1), 45-48.
13. Morency-Curran, N. The Nuprin Pain Report; Louis Harris & Associates, Inc.: New York, 1985.
14. Mercadante, S. Malignant bone pain: pathophysiology and treatment. Pain 1997, 69(1-2), 1-18.
15. Walley, B.A.; Hagen, N.A. The epidemiology of cancer pain. Pain Dig. 1995, (5), 237-244.
16. Graven-Nielson, T.; Mense, S. The peripheral apparatus of muscle pain: evidence from animal and human studies. Clin. J. Pain 2001, 17 (1), 2-10.
17. Mense, S. Pathophysiologic basis of muscle pain syndromes: an update. Phys. Med. Rehabil. Clin. North Am. 1997, 8 (1), 23-53.
18. Julius, D.; Basbaum, A.I. Molecular mechanisms of nociception. Nature 2001, 413 (6852), 203-210.
19. Mork, H.; Ashina, M.; Bendtsen, L.; Diesen, J.; Jensen, R. Experimental muscle pain and tenderness following infusion of endogenous substances in humans. Eur. J. Pain 2003, 7 (2), 145-153.
20. Mense, S.; Simons, D.G. Muscle Pain: Understanding Its Nature. Diagnosis, and Treatment; Lippincott, Williams. & Wilkins: Baltimore, MD. 2001; 32.
21. Mense, S. Reduction of the Brady-Kinin-induced activation of feline group III and IV muscle receptors by acetylsalicylic acid. J. Physiol. 1982, 326, 263-283.
22. Sicuteri, F. Vasoneuroactive substances and their implication in vascular pain. Res. Clin. Stud. Headache 1967, 1, 6-45.
23. Khasabov, S.G.; Rogers, S.D.; Ghilardi, J.R.; Peters, C.M.; Mantyh, P.W.; Simone, D.A. Spinal neurons that possess the substance P receptor are required for the development of central sensitization. J. Neurosci. 2002, 22 (20), 9086-9098.
24. Mense, S.; Hoheisel, U. A lack: of NO in the spinal cord as a possible factor for the occurrence of spontaneous pain. Schmerz 2001, 15 (1), 19-25.
25. Dugan, S.A.; Frontera, W.R. Muscle fatigue and muscle injury. Phys. Med. Rehabil. Clin. North Am. 2000, 11 (2), 385-402.
26. Twycross, R.; Fairfield, S. Pain in advanced cancer. Pain 1982, 14 (3), 303-310.
27. Simons, D.G. Myofascial pain syndromes due to trigger points. In Pain and Disability: Clinical, Behavioral, and Public Policy Perspectives; Osterweis, M., Kleinman, A., Mechanic, D., Eds.; National Academy Press: Washington, DC, 1987; 285-292.
28. Deyo, R.A.; Weinstein, J.N. Low back pain. N. Engl. J. Med. 2001, 344, 363-370.
29. Twycross, R. Cancer pain classification. Acta Anaesthesiol. Scand. 1997, 41 (1 Pt. 2), 141-145.
30. Sola, A.E.; Rodenberger, M.L.; Gettya, D.B. Incidence of hypersensitive areas in posterior shoulder muscles. Am. J. Phys. Med. 1955, 34, 585.
31. Travell, J. Myofascial trigger points: clinical view. In Advances in Pain Research and Therapy I; Bonica, J.J., Albe-Fessard, D., Eds.; Raven Press: New York, 1976; 919-926.
32. Kraus, H.; Marcus, N.J. The reintroduction of an exercise program to directly treat low back pain of muscular origin. J. Back Musculoskelet. Rehabil. 1997, 8 (2), 95-107.
33. Marcus, N.J. Diagnosis of myofascial pain. In Advancements in the Treatment of Neuromuscular Pain; The Office of Continuing Medical Education at Johns Hopkins University: Baltimore, MD, 2000; 161-166.
34. Rachlin, E.S. Myofascial Pain and Fibromyalgia: Trigger Point Management; Mosby: London, 1994.
35. Kraus, H. Clinical Treatment of Back and Neck Pain; McGraw-Hill: New York, 1970, Chapter 4.
36. Bloomfield, S.A. Changes in musculoskeletal structure and function with prolonged bed rest. Med. Sci. Sports Exerc. 1995, 29, 197-206.
37. Siegel, T. Muscle cramps in the cancer patient: causes and treatment. J. Pain Symptom Manage. 1991, 6, 147.
38. Fisher, A.A.; Chang, C.H. Electromyographic evidence of paraspinal muscle spam during sleep in patients with low back pain. Clin. J. Pain 1985, 3, 147.
39. Mills, K.R.; Newham, D.F.; Edwards, R.H.T. Muscle pain. In Textbook of Pain; Wall, P., Melzack, R., Eds.; Churchill Livingstone: Edinburgh, 1984; 319-330.
40. Travell, J.G.; Simons, D.G. Travell and Simons' Myofascial Pain and Dysfunction: The Trigger Point Manual, 2nd Ed.; Simons, D.G., Travell, J.G., Simons, L.S., Eds.; Williams & Wilkins: London. 1999; Vol. 1.
41. Diagnosis and Treatment of Muscle Pain; Kraus, H., Ed.; Quintessence: Chicago, 1988.
42. Fisher, A.A. Functional diagnosis of musculoskeletal pain and evaluation of treatment results by quantitative and objective methods. In Myofascial Pain and Fibromyalgia: Trigger Point Management; Rachlin, E.S., Ed.
43. Kraus, H. Muscle deficiency. In Myofascial Pain and Fibromyalgia: Trigger Point Management; Rachlin, E., Ed.; Mosby: London, 1994; 385-414.
44. Kraus, H. The Sports Injury Handbook; Nick Lyons Books: New York, 1981.
45. Kraus, H.; Eisenmenger-Weber, S. Fundamental considerations of posture exercises. Physiother. Rev. 1947, 27, 361-368.
46. Kraus, H.; Nagler, W.; Melleby, A. Evaluation of an exercise program for back pain. Am. Fam. Phys. 1983, 28 (3), 153-158.
47. Preibisch, C.; Berg, D.; Hofman, E.; Solymosi, L.; Naumann, M. Cerebral activation patterns in patients with writer's cramp: a functional magnetic resonance imaging study. J. Neurol. 2001, 248 (1), 10-17.
48. Rosenkranz, K.; Altenmuller, E.; Siggelkow, S.; Dengler, R. Alteration of sensorimotor integration in musician's cramp: impaired focusing of proprioception. Clin. Neurophysiol. 2000, 111 (11), 2040-2045.
49. Ibanez, V.; Sadato, N.; Karp, B.; Deiber, M.P.; Hallett, M. Deficient activation of the motor cortical network in patients with writer's cramp. Neurology 1999, 53 (1), 96-105.
50. Jansen, P.H.; Lecluse, R.G.; Verbeek, A.L. Past and current understanding of the pathophysiology of muscle cramps: why treatment of varicose veins does not relieve leg cramps. J. Eur. Acad. Dermatol. Venereol. 1999, 12 (3), 222-229.
51. Serrao, M.; Rossi, P.; Cardinali, P.; Valente, G.; Parisi, L.; Pierelli, F. Gabapentin treatment for muscle cramp: an open-label trial. Clin. Neuropharmacol. 2000, 23 (1), 45-49.
52. Bertolasi, L.; Priori, A.; Tomelleri, G.; Bongiovanni, L.G.; Fincati, E.; Simonati, A.; De Grandis, D.; Rizzuto, N. Botulinum toxin treatment of muscle cramps: a clinical and neurophysiological study. Ann. Neurol. 1997, 41 (2), 181-186.
53. Jones, K.; Castleden, C.M. A double blind comparison of quinine sulphate and placebo in muscle cramps. Age Ageing 1983, 12, 155-158.
54. Henry, J.A. Quinine for night cramps. Br. Med. J. 1985, 291, 3.
55. Boland, M.E.; Brennand Roper, S.M.; Henry, J.A. Complications of quinine poisoning. Lancet 1985, 1, 384-407.
56. Webster, L.T., Jr. Drugs used in the chemotherapy of protozoal infections. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th Ed.; Goodman Gilman, A., Rall, T.W., Nies, A.S., Taylor, P., Eds.; McGraw-Hill: New York, 1990; 992.
57. De Lateur, B.J. Flexibility. Phys. Med. Rehabil. Clin. North Am. 1994, 5 (2), 295-307.
58. Starr, M. Theory and practice of myofascial pain as both practicing clinician and patient. J. Back Musculoskelet. Rehabil. 1997, 8 (2), 173-176.